Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
4.790
-0.210 (-4.20%)
Feb 21, 2025, 4:00 PM EST - Market closed
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $226.16 million as of February 21, 2025. Its market cap has decreased by -72.35% in one year.
Market Cap
226.16M
Enterprise Value
53.46M
1-Year Change
-72.35%
Ranking
Category
Stock Price
$4.79
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $226.16M, a decrease of -57.99%. That is a compound annual growth rate of -17.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 226.16M | -30.38% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |